Chief Executive Officer of Kymera Therapeutics, Inc. (U.S.: Nasdaq:KYMR), Mainolfi Nello, sells 22,465 shares worth $1,196,397
According to Kymera Therapeutics, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 07:30 PM, company Chief Executive Officer, Mainolfi Nello disclosed selling 22,465 shares at a cost of $53.26. At the time of this transaction (Jan 10), this trade was worth $1,196,397 in total. As of Jan 10, Mainolfi Nello now owns 472,199 shares in total worth about $21,310,340.87.
For the last few recent trades made by Kymera Therapeutics, Inc. (U.S.: Nasdaq:KYMR) Chief Executive Officer, Mainolfi Nello, we have the following information:
- SEC Form 4 filing: Jan 11: Sold 16,923 shares at the rate of $54.00 per share. Total worth of this trade was $913,795. Total number of shares owned as of Jan 11 were 472,199
- SEC Form 4 filing: Jan 12: Sold 8,612 shares at the rate of $52.08 per share. Total worth of this trade was $448,551. Total number of shares owned as of Jan 12 were 472,199
- SEC Form 4 filing: Oct 08: Sold 41,544 shares at the rate of $56.76 per share. Total worth of this trade was $2,357,946. Total number of shares owned as of Oct 08 were 464,199
Posted by
George Daniels
on Thursday January 13 2022, 2:42 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
